Stress cardiomyopathy secondary prevention: Difference between revisions
Jump to navigation
Jump to search
Dima Nimri (talk | contribs) |
No edit summary |
||
| (One intermediate revision by the same user not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{CMG}} | |||
{{CMG}}{{AE}}{{Sab}} | |||
{{Stress cardiomyopathy}} | {{Stress cardiomyopathy}} | ||
==Overview== | ==Overview== | ||
Stress cardiomyopathy is a self-limiting disease, which usually resolves within a few weeks. However, medical therapy may be necessary during the acute phase of the illness or when complications arise. | [[Stress (medicine)|Stress]] [[cardiomyopathy]] is a [[self-limiting]] [[disease]], which usually resolves within a few weeks. However, medical [[therapy]] may be necessary during the [[Acute (medicine)|acute]] phase of the [[illness]] or when [[Complication (medicine)|complications]] arise. | ||
==Secondary Prevention== | ==Secondary Prevention== | ||
Stress cardiomyopathy is a self-limiting disease, which usually resolves within a few weeks. | * [[Stress (medicine)|Stress]] [[cardiomyopathy]] is a [[self-limiting]] [[disease]], which usually resolves within a few weeks. | ||
* Medical [[therapy]] may be necessary during the [[Acute (medicine)|acute]] phase of the [[illness]] or when [[Complication (medicine)|complications]] arise.<ref name="pmid27538839">{{cite journal |vauthors=Brunetti ND, Santoro F, De Gennaro L, Correale M, Kentaro H, Gaglione A, Di Biase M |title=Therapy of stress (takotsubo) cardiomyopathy: present shortcomings and future perspectives |journal=Future Cardiol |volume=12 |issue=5 |pages=563–72 |year=2016 |pmid=27538839 |doi=10.2217/fca-2016-0014 |url=}}</ref> | |||
==References== | ==References== | ||
Latest revision as of 20:47, 1 February 2019
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Sabawoon Mirwais, M.B.B.S, M.D.[2]
|
Stress cardiomyopathy Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Unstable angina/non ST elevation myocardial infarction in Stress (Takotsubo) Cardiomyopathy |
|
Case Studies |
|
Stress cardiomyopathy secondary prevention On the Web |
|
American Roentgen Ray Society Images of Stress cardiomyopathy secondary prevention |
|
Risk calculators and risk factors for Stress cardiomyopathy secondary prevention |
Overview
Stress cardiomyopathy is a self-limiting disease, which usually resolves within a few weeks. However, medical therapy may be necessary during the acute phase of the illness or when complications arise.
Secondary Prevention
- Stress cardiomyopathy is a self-limiting disease, which usually resolves within a few weeks.
- Medical therapy may be necessary during the acute phase of the illness or when complications arise.[1]
References
- ↑ Brunetti ND, Santoro F, De Gennaro L, Correale M, Kentaro H, Gaglione A, Di Biase M (2016). "Therapy of stress (takotsubo) cardiomyopathy: present shortcomings and future perspectives". Future Cardiol. 12 (5): 563–72. doi:10.2217/fca-2016-0014. PMID 27538839.